The generation of induced pluripotent stem (iPS) cells presents a challenge to normal developmental processes. The low efficiency and heterogeneity of most methods have hindered understanding of the precise molecular mechanisms promoting, and roadblocks preventing, efficient reprogramming. Although several intermediate populations have been described [1] [2] [3] [4] [5] [6] [7] , it has proved difficult to characterize the rare, asynchronous transition from these intermediate stages to iPS cells. The rapid expansion of minor reprogrammed cells in the heterogeneous population can also obscure investigation of relevant transition processes. Understanding the biological mechanisms essential for successful iPS cell generation requires both accurate capture of cells undergoing the reprogramming process and identification of the associated global gene expression changes. Here we demonstrate that in mouse embryonic fibroblasts, reprogramming follows an orderly sequence of stage transitions, marked by changes in the cell-surface markers CD44 and ICAM1, and a Nanog-enhanced green fluorescent protein (Nanog-eGFP) reporter. RNA-sequencing analysis of these populations demonstrates two waves of pluripotency gene upregulation, and unexpectedly, transient upregulation of several epidermisrelated genes, demonstrating that reprogramming is not simply the reversal of the normal developmental processes. This novel high-resolution analysis enables the construction of a detailed reprogramming route map, and the improved understanding of the reprogramming process will lead to new reprogramming strategies.
Several reports have suggested that reprogramming progresses in an ordered manner 3, 5, 6, [8] [9] [10] . To identify markers whose expression changed concurrent with pluripotency gene expression, we performed time course microarray analysis using a piggyBac transposon-based secondary reprogramming system 3, 11 ( Supplementary Fig. 2a ). Of a number of candidate cell-surface markers, Cd44 and Icam1 (also known as CD54) demonstrated the most dynamic expression changes throughout secondary mouse embryonic fibroblast (MEF) reprogramming ( Supplementary Fig. 2b ). For further investigation, we generated an efficient secondary reprogramming system in which doxycyclinemediated induction of the reprogramming factors could be monitored by an mOrange reporter placed after the 2A-peptide-linked reprogramming cassette c-Myc-Klf4-Oct4-Sox2 (MKOS) 12 , and endogenous Nanog promoter activation could be followed by expression of enhanced green fluorescent protein (eGFP) 13 ( Supplementary Fig 3) . Reprogramming cultures were supplemented with vitamin C and an Alk inhibitor, both of which enhance reprogramming efficiency 10, 14, 15 . In this secondary reprogramming system, Nanog-eGFP 1 cells appeared as early as day 6, and .60% of mOrange 1 transgene-expressing cells were found to be Nanog-eGFP 1 by day 12 ( Supplementary Figs 4  and 5a ). Most mOrange 1 transgene-expressing cells lost expression of Thy1 (also known as CD90) and gained E-cadherin (also known as Cdh1) expression by day 4 ( Supplementary Fig. 5b , c). Expression of stage-specific embryonic antigen 1 (SSEA-1, also known as Fut4) barely changed after day 8, with a gradual gain of Nanog-eGFP 1 cells in both SSEA-1 1 and SSEA-1 2 cell populations ( Supplementary Fig. 5d ). Consistent with heterogeneous expression of SSEA1 in iPS and embryonic stem (ES) cells, it was not possible to delineate the reprogramming process accurately using SSEA-1 ( Supplementary Fig. 6 ). By contrast, the appearance of CD44 2 and ICAM1 1 cells at later time points closely correlated with Nanog-eGFP expression ( Supplementary Fig. 5e , f). Double staining for CD44 and ICAM1 revealed that a distinct series of population changes occur during reprogramming ( Fig. 1 ). Initially, MEFs displayed high CD44 and broad ICAM1 expression, with most becoming ICAM1 2 by day 6, along with the appearance of a minor CD44 2 ICAM1 2 cell population. By day 8, CD44 2 populations appeared enriched, and at day 12 almost all cells displayed an iPS/EScell-like CD44 2 ICAM1 1 profile, of which more than 60% expressed Nanog-eGFP. Consistent with the observation that Nanog expression is not necessarily a sign of completed reprogramming 16 , Nanog-eGFP 1 cells were observed even before cells obtained this iPS/ES-cell-like phenotype (CD44 2 ICAM1 1 ). Both ICAM1 1 -and ICAM1 2 -sorted MEFs demonstrated similar fluorescence-activated cell sorting (FACS) profile changes during reprogramming ( Supplementary Fig. 7 ). Immunofluorescence for CD44 and ICAM1 revealed that reprogramming is not synchronized even within individual colonies (Supplementary Fig. 8 ). Secondary reprogramming of the non-polycistronic iPS cell line 6c (refs 3, 11) and primary reprogramming using MKOS and Oct4-P2A-Sox2-T2A-Klf4-E2A-cMyc (OSKM) 17 piggyBac transposons resulted in similar ICAM1 and CD44 profile changes, indicating their suitability for use in other systems and contexts ( Supplementary Fig. 9 ). These findings demonstrated the asynchronous but stepwise manner of reprogramming, and highlighted the potential usefulness of CD44 and ICAM1 to isolate intermediate reprogramming subpopulations.
Next, we aimed to confirm that the observed CD44/ICAM1 profile changes reflected the transition of individual cells from one stage to the next, and not merely the loss of one major population and expansion of another minor population. CD44 1 ICAM1 2 (gate 1), CD44 2 ICAM1 2 (gate 2) and CD44 2 ICAM1 1 (gate 3) cell populations, either Nanog-eGFP 1 (that is, 1NG 1 , 2 NG 1 and 3NG 1 ) or Nanog-eGFP 2 (1NG 2 , 2NG 2 and 3NG 2 ), were isolated by cell-sorting at day 10 of reprogramming and re-plated in reprogramming conditions ( Fig. 2a ). After 3 days, both NG 1 and NG 2 cells progressed in the order of gates 1 to 2 to 3 ( Fig. 2b ). This progression correlated well with increased Nanog-eGFP 1 colony-forming potential (c.f.p.), with 3NG 1 cells displaying similar clonogenicity to fully reprogrammed iPS cells ( Fig. 2c ). Of cells with the same CD44/ICAM1 profile, Nanog-eGFP expression correlated with a higher c.f.p. (for example, 1NG 2 versus 1NG 1 ).
To examine the progression of the reprogramming process more accurately, cells from each gate were sorted, and their expression of CD44/ ICAM1/Nanog-eGFP was re-analysed after 24 h ( Fig. 2d ). On the basis of total cell numbers in each gate after 24 h ( Supplementary Fig. 10 ), we generated a reprogramming route map representing differences in the efficiency of these stage transitions and in Nanog-eGFP 1 c.f.p. (Fig. 2e ). Similar results were obtained when each subpopulation was sorted at day 8 ( Supplementary Fig. 11 ). This analysis revealed that reaching a Nanog-eGFP 1 state is a rate-limiting step-as few cells overcame this barrier in the 24 h assay-and those that do so reprogram more efficiently than their Nanog-eGFP 2 counterparts, consistent with the role of Nanog as an accelerator of reprogramming and the gateway to pluripotency 18, 19 .
To determine global gene expression changes during these stage transitions, we carried out RNA-sequencing analysis using a highly multiplexed sample bar-coding system [20] [21] [22] [23] [24] [25] [26] (see Methods and Supplementary Table 1 ). Hierarchical clustering using the complete list of differentially expressed genes (DEGs) revealed four major branches: (1) MEFs; (2) 1NG 2/1 and 2NG 2 ; (3) 2NG 2/1 and 3NG 2/1 ; and (4) 3NG 1 sorted at day 15 (3NG 1 D15), iPS and ES cells ( Fig. 3a ). There was a prominent gene expression difference between 3NG 1 and 3NG 1 D15 cells, with the latter being more similar to iPS and ES cells ( Fig. 3a and Supplementary Fig. 12 Fig. 13 ). The DEGs between these two populations may be involved in the establishment of an exogenous-factor-independent self-renewal state. Principal component analysis clearly distinguished 2NG 1 from 3NG 2 cells, consistent with the higher probability of the former to reach the 3NG 1 state within 24 h ( Supplementary Figs 10 and 12b ). DEGs could be classified into five distinct expression pattern groups (A-E) ( Fig. 3a and Supplementary Tables 2 and 3 ). Group A contained readily downregulated fibroblast-related genes. Group D comprised factors gradually upregulated towards iPS cells, in which ES cell genes were highly enriched (P # 0.000367) ( Fig. 3c) . However group C, which contained genes upregulated at early stages and maintained throughout reprogramming, also included some pluripotency-related factors. To extend this finding, we examined the expression pattern of 22 pluripotency-related genes in our data set 27, 28 . Interestingly, 8 pluripotency genes, including endogenous Oct4 (also known as Pou5f1), were already upregulated at the 1NG 1 /2NG 2 stages to the level found in 3NG 1 cells (Fig. 3b, left) , whereas 14 pluripotency genes were more gradually upregulated in the later stage reprogramming populations (Fig. 3b, right, and Supplementary Table 4 ). This early and late pluripotency gene upregulation was confirmed at the single cell level 5 (Fig. 3e) , highlighting the high resolution of the CD44/ICAM1 sorting system. We also identified two additional gene expression patterns displaying transient upregulation (group B) or downregulation (group E) exclusively in the intermediate stages of reprogramming. This finding indicates that reprogramming from MEFs to iPS cells is not simply the loss of MEF genes and gain of ES cell genes. Gene Ontology analysis revealed that genes related to ectoderm/epidermis development and keratinocyte differentiation were highly enriched in group B (P # 0.000274) (Fig. 3c, d and Supplementary Tables 3-5 ). Although SFN and KRT17 were barely detectable by immunofluorescence in MEFs and iPS cells, transient upregulation was observed in the intermediate stages of reprogramming ( Supplementary Fig. 14) . Single-cell PCR confirmed the co-expression of epidermis genes (Ehf and Ovol1) with early pluripotency genes in the 1NG 2/1 stage (Fig. 3e ). Consistent with our data, analysis of three published microarray data sets incorporating partially reprogrammed iPS cells 1 , a time course experiment 3 and a subpopulation analysis with Thy1, SSEA-1 and Oct4-eGFP (ref. 6) confirmed transient epidermal gene expression during reprogramming ( Supplementary Figs 15-17 and Supplementary Tables 6-8 ). Partially reprogrammed cells from B cells also displayed similar epidermis gene expression 4 , whereas two factorreprogramming (Oct4 and Sox2) of MEFs did not 29 . Therefore, this intermediate state could be a consequence of the use of Klf4 that is important for efficient reprogramming, and demonstrates that the reprogramming process is not simply a reversion of normal differentiation (summarized in Supplementary Fig. 1 ). It would be intriguing to investigate whether similar transient gene expression changes can be seen in reprogramming of ectoderm or endoderm lineages. Downregulation of these epidermis genes coincided with upregulation of 'late' pluripotency genes. Future examination of this rapid switch in gene expression may provide a new insight into the molecular mechanism of reprogramming. 
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The integrative data analysis described above demonstrated that this CD44/ICAM1/Nanog-eGFP marker system could uniquely provide high-resolution information during late pluripotency gene upregulation, enabling the discrimination of 'reprogramming' from 'expansion of reprogrammed cells' (Fig. 3b and Supplementary Figs 16b and 17f) . This system also refines investigation of the kinetics of reprogramming. It has recently been shown that vitamin C increases reprogramming efficiency by facilitating histone 3 Lys 9 (H3K9) demethylation 7 , and that reprogramming factors fail to bind trimethylated H3K9-rich regions in the initial stages of reprogramming 30 . We carried out reprogramming in the absence of vitamin C and observed not only a decrease in the iPS cell colony number, but also a marked delay in the transition from one stage of reprogramming to the next (Supplementary Fig. 18 ). Similar analyses can be performed using our marker system to investigate the mechanism of action of other factors that alter reprogramming efficiency. Isolation and analysis of subpopulations affected by these factors could reveal the downstream genes specifically involved in, and required for, successful reprogramming. Further studies using this high-resolution analysis system have the potential to make a considerable contribution towards revealing the molecular mechanisms of reprogramming.
METHODS SUMMARY
The vector PB-TAP IRI 2LMKOSimO, a modified version of polycistronic reprogramming vector pCAG2LMKOSimO (ref. 12) , containing insulator and replicator sequences and driven by the tetO 2 promoter, was constructed as described in the Methods. This vector was used to generate iPS cell line D6s4B5 from reverse tetracycline transactivator (rtTA)-expressing MEFs carrying a Nanog-eGFP reporter 13 . D6s4B5 iPS cells were used to generate chimaeric embryos from which MEFs were isolated at embryonic day 12.5. Transgenic MEFs were cultured in doxycycline (300 ng ml 21 ), vitamin C (10 mg ml 21 ) and Alk inhibitor (500 nM), and collected for flow cytometry analysis (BD Fortessa), carried out using antibodies for CD44 and ICAM1 every 2-3 days. Cells were sorted (BD FACS Aria II) at day 10 or 15, and replated on gelatin for analysis at 24 h, or at clonal density on irradiated MEFs for Nanog-eGFP 1 c.f.p. 10 days after cell sorting. All flow cytometry data were analysed using FlowJo (Tree Star). Immunofluorescence was carried out using confocal microscopy (Leica TSC SP2). RNA from sorted samples was extracted using Trizol (Invitrogen), and 10 ng total RNA was used for multiplexed RNA-sequencing 20, 21 . Data were analysed using GeneProf 22 , and DEGs were identified using edgeR and DESeq Bioconductor libraries [23] [24] [25] . Gene Ontology enrichment was calculated using DAVID 26 .
